Xunlian Exosome Foundry becomes the highlight of the Biotech Expo. Five international brands’ successful cases are published to attract all walks of life to join the trillion-dollar biotech industry.

Exosome Foundry will be held on July 26th, with five internationally renowned companies presenting their success stories, bringing regenerative medicine from the operating room to the dressing table of every household.

Taipei--- Exosomes, a rising star in regenerative medicine, have become the focus of competition in the global biotech arena, and Taiwan has a clear chance of winning. Deputy Minister of Economic Affairs Ho Chin-cang specifically named exosomes as the most promising new technology in regenerative medicine, with huge market potential. Xunlian has been investing in exosome research and development since 2002 , leading the layout of the exosome market. Today, with the cooperation of multinational brands, combined with localized and customized services, it has launched a new business model of " Exosome Foundry Global R&D OEM", attracting nearly 150 domestic and foreign companies to participate in the event, hoping that through the introduction and application of various exosomes, the value of products will increase, help the industry upgrade, and jointly accelerate the realization of the trillion-dollar biotech industry.

Government opinion: Exosomes are expected to lead the biotech industry to global success

Taiwan's biomedical strength is strong, and related policies and regulations are also advancing with the times. The Ministry of Health and Welfare passed the regenerative medicine law in June this year, announcing the vigorous development of Taiwan's biotech industry. Ho Chin-cang, Deputy Minister of Economic Affairs of the Ministry of Economic Affairs, pointed out that the government has actively promoted legislative reforms in recent years, hoping to accelerate the development of regenerative medical technology, especially in the field of exosomes, which can not only be used to treat cancer, neurodegenerative diseases and autoimmune diseases, but also expand to the fields of beauty and regenerative medicine. The market scale is considerable. It is expected that the investment and innovation of biotech companies will drive the development speed of domestic exosome new drugs, expand the application of exosomes in our daily lives, and further promote Taiwan's exosome industry to a global leading position.

Since 25 years ago, Shunlian Biotech has pioneered the development of stem cell regenerative medicine in Taiwan. Now, it has introduced the foundry business model, giving new regenerative medicine value to each fast-growing industry, helping to increase the unit price of goods and services, such as the growth of medical aesthetics treatments by 1.3 times and beauty care products by 5 times. At the same time, it can create market demand and expand the number of consumers, thereby forming economies of scale. It can be described as the TSMC and Pfizer in the biotech industry. According to market estimates, the global exosome economy in the fields of cosmetics, medical beauty, pets, and medicine will reach 1.29 trillion US dollars in 2032 . Tsai Cheng-hsien, chairman of the Xunlian Group, pointed out that the application of regenerative medicine in all walks of life and fields will help transform traditional industries, connect to the global market, and accelerate the overall development of Taiwan's biotechnology and pharmaceutical fields . 

Exosome Foundry helps regenerative medicine move from the operating room to the dressing table of every household

Exosome Foundry today (26th ) published successful cases from various countries, such as Lumenis , the world's leading laser photoelectric brand . Its main facial photoelectric treatment "Heart-moving Light Shuttle" can smoothly open the "light channel" in the skin for exosomes to enter effectively, shortening the recovery period of the treatment. It has shown great potential in modern medicine and beauty care, and helps to comprehensively upgrade medical beauty treatments. Lumenis General Manager Lin Shangwei said that each batch of Xunlian's next-generation exosomes has high biological activity and performs very well in clinical applications combined with photoelectric treatments. SAINDERMA , a high-end French medical beauty brand , also combines exosome care with the American high-tech TargetCool technology. Through instant cooling technology, it transforms exosomes into ice crystal particles and introduces them into the skin, achieving all-round evolutionary skin care.

THANN , a fashion fragrance skincare brand that has been advocating natural aesthetics for 22 years , has teamed up with Xunlian to launch a co-branded exosome mask. Through stem cell exosomes and Oriental Orchard's powerful moisturizing mask, it will be officially sold at THANN stores in SOGO Zhongxiao this month, and is expected to be promoted to 21 countries around the world in the future; HAPPY HAIR/GENIC , the most refined chain salon brand in the Chinese world, uses exosomes to upgrade scalp care, strengthen hair roots, and provide home hair care services. In addition to product development, Exosome Foundry also provides exosome raw materials, such as Ladies Biotech , a biotech cosmetics factory that is marketed globally , which displays more than 20 exosome skincare products from toners, essences, masks, eye creams, and creams .

Exosome Foundry has established a shortcut for the cosmetics industry, medical beauty equipment, medical institutions, and OEM factories to enter the field of regenerative medicine, enhancing the brand's international competitive advantage. It has also created a variety of unprecedented new exosome business services, allowing regenerative medicine to enter all walks of life.